Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.550
-0.080 (-4.91%)
At close: Feb 25, 2026, 4:00 PM EST
1.590
+0.040 (2.58%)
After-hours: Feb 25, 2026, 5:50 PM EST
Marker Therapeutics Market Cap
Marker Therapeutics has a market cap or net worth of $25.84 million as of February 25, 2026. Its market cap has increased by 63.57% in one year.
Market Cap
25.84M
Enterprise Value
8.25M
1-Year Change
63.57%
Ranking
Category
Stock Price
$1.55
Market Cap Chart
Since November 8, 2016, Marker Therapeutics's market cap has decreased from $45.80M to $25.84M, a decrease of -43.57%. That is a compound annual growth rate of -5.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 27.20M | 9.68% |
| Dec 31, 2025 | 24.80M | -10.79% |
| Dec 31, 2024 | 27.80M | -43.15% |
| Dec 29, 2023 | 48.90M | 120.27% |
| Dec 30, 2022 | 22.20M | -71.86% |
| Dec 31, 2021 | 78.90M | 13.36% |
| Dec 31, 2020 | 69.60M | -47.15% |
| Dec 31, 2019 | 131.70M | -47.70% |
| Dec 31, 2018 | 251.80M | 509.69% |
| Dec 29, 2017 | 41.30M | 27.08% |
| Dec 30, 2016 | 32.50M | -29.04% |
| Nov 8, 2016 | 45.80M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evaxion | 28.94M |
| Lantern Pharma | 28.74M |
| AN2 Therapeutics | 28.50M |
| NeuroSense Therapeutics | 27.35M |
| Reviva Pharmaceuticals Holdings | 26.86M |
| IGC Pharma | 26.72M |
| BriaCell Therapeutics | 26.56M |
| Klotho Neurosciences | 26.38M |